6451 - 6460 of 8587 Results
Title
Year
-
OPENTitle: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s DiseaseJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 15Issue #: 5Start Page: 8592End Page: 8609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.1c00453Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c00453Citation Count: 79
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 7
- Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice2021OPENTitle: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic miceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 16Start Page: 1469End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab118Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/16/1469/39351981/ddab118.pdfCitation Count: 17
-
OPENTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020Citation Count: 16
-
OPENTitle: Human pegivirus alters brain and blood immune and transcriptomic profiles of patients with Parkinson’s diseaseJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.189988Best OA location URL: https://devel-insight.jci.org/articles/view/189988/files/pdfCitation Count: 0
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 63
-
OPENTitle: Personality and reported quality of life in Parkinson's diseaseJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 32Issue #: 3Start Page: 324End Page: 330Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.4475Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5333497Citation Count: 24
-
OPENTitle: GBA mutations are associated with Rapid Eye Movement Sleep Behavior DisorderJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 9Start Page: 941End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.228Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.228Citation Count: 137
-
OPENTitle: Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Best OA location URL: https://doi.org/10.1016/j.isci.2024.110956Citation Count: 1
-
OPENTitle: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) CellsJournal Name: BiomoleculesPublisher: MDPI AGVol: 14Issue #: 6Start Page: 647End Page: 647Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom14060647Best OA location URL: https://www.mdpi.com/2218-273X/14/6/647/pdf?version=1717136963Citation Count: 3